January 2009 Volume 5 Number 1
Visit Nature Clinical Practice Nephrology online to browse the journal.
Now available at http://links.ealert.nature.com/ctt?kn=20&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
=====================================================================
===========================ADVERTISEMENT=============================
Renew your ISN membership today! receive reduced rate and reclaim your
member benefits
- 24 x Kidney International
- 12 NCP Nephrology
- Full access to the Gateway
- Special rates at ISN's international Events
http://links.ealert.nature.com/ctt?kn=60&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
=====================================================================
===========================ADVERTISEMENT=============================
This year, Modern Pathology makes its mark.
Modern Pathology is:
-One of the top two journals dedicated to general diagnostic anatomic
pathology
-The #6 journal in general pathology
-Now with an impact factor of 4.286
Innovative findings in clinical and translational research in the
pathology of human disease for over 20 years. Visit Modern Pathology
online at http://links.ealert.nature.com/ctt?kn=57&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
=====================================================================
----------------------
EDITORIAL
----------------------
What have nephrologists and cardiologists learnt from each other?
Eberhard Ritz and Andrew Remppis
http://links.ealert.nature.com/ctt?kn=9&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
----------------------
RESEARCH HIGHLIGHTS
----------------------
Inability to monitor renal function is not a contraindication to first-line
HAART
http://links.ealert.nature.com/ctt?kn=2&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
Cystatin C is 'better than' creatinine for GFR estimation in adults with
cystic fibrosis
http://links.ealert.nature.com/ctt?kn=11&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
MYH9 is associated with kidney disease in African Americans
http://links.ealert.nature.com/ctt?kn=31&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
Losartan and vitamin D analog synergistically prevent diabetic nephropathy
in mice
http://links.ealert.nature.com/ctt?kn=27&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
Combination therapy is the most effective option for severe lupus nephritis
http://links.ealert.nature.com/ctt?kn=36&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
Cardiac rehabilitation after coronary bypass is cost-effective in patients
on dialysis
http://links.ealert.nature.com/ctt?kn=58&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
Early steroid withdrawal is feasible after ABO-incompatible renal
transplantation
http://links.ealert.nature.com/ctt?kn=24&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
Patterns of primary graft dysfunction in recipients of organs from
multiorgan donors
http://links.ealert.nature.com/ctt?kn=5&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
Urinary fractalkine level: a potential marker of acute renal allograft
rejection
http://links.ealert.nature.com/ctt?kn=73&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
----------------------
PRACTICE POINTS
----------------------
The effects of hormone replacement therapy on renal function
Sharon Silbiger
http://links.ealert.nature.com/ctt?kn=39&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
Women with a history of preeclampsia should be monitored for the onset
and progression of chronic kidney disease
Takayuki Hamano
http://links.ealert.nature.com/ctt?kn=48&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
Fluid balance and acute kidney injury: the missing link for predicting
adverse outcomes?
Ravindra L Mehta
http://links.ealert.nature.com/ctt?kn=19&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
Re-examining RAS-blocking treatment regimens for abrogating progression
of chronic kidney disease
Murray Epstein
http://links.ealert.nature.com/ctt?kn=65&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
Does increased removal of high-molecular-weight toxins improve the survival
of hemodialysis patients?
Richard A Ward
http://links.ealert.nature.com/ctt?kn=1&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
Interpreting observational studies of disordered mineral metabolism and
mortality in patients on hemodialysis
David M Spiegel
http://links.ealert.nature.com/ctt?kn=23&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
The advantage of live-donor kidney transplantation in older recipients
Lisa Nanovic and Bruce Kaplan
http://links.ealert.nature.com/ctt?kn=53&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
----------------------
VIEWPOINTS
----------------------
HIV-related renal disease and the utility of empiric therapy-not everyone
needs to be biopsied
Lynda A Szczech
http://links.ealert.nature.com/ctt?kn=7&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
Renal biopsy is necessary for the diagnosis of HIV-associated renal diseases
Scott D Cohen and Paul L Kimmel
http://links.ealert.nature.com/ctt?kn=32&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
----------------------
REVIEWS
----------------------
Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in
end-stage renal disease: time for a paradigm shift?
James B Wetmore and L Darryl Quarles
http://links.ealert.nature.com/ctt?kn=26&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
The advantages and challenges of increasing the duration and frequency of
maintenance dialysis sessions
Charles Chazot and Guillaume Jean
http://links.ealert.nature.com/ctt?kn=17&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
Immunizations for renal transplant candidates and recipients
Jennifer Cohn and Emily A Blumberg
http://links.ealert.nature.com/ctt?kn=21&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
----------------------
CASE STUDY
----------------------
Monoclonal gammopathy and glomerulopathy associated with chronic lymphocytic
leukemia
Eswari Vilayur, Paul Trevillian and Mark Walsh
http://links.ealert.nature.com/ctt?kn=66&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
=====================================================================
You submitted your paper months ago. Still no answer? Stop waiting and
submit to Laboratory Investigation and receive a first decision within
15 working days.
Our editorial office prides itself on fast efficient peer-review and
believes in a thorough, yet timely review of submitted papers.
Why submit?
-Impact factor of 4.479*
-Advanced Online Publication 31 days from paper acceptance
-Ranked in the top five of pathology journals
Read the Full Guide to Authors at link to:
http://links.ealert.nature.com/ctt?kn=51&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
=====================================================================
You have been sent this Table of Contents Alert because you have opted
in to receive it. You can change or discontinue your e-mail alerts at
any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=22&m=30750443&r=MTQ3MzYzMTc4MAS2&b=2&j=NDQyODA5NjkS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact our customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
=====================================================================
